Markets

  • NHS to offer cutting-edge support for tens of thousands living with obesity

    Tens of thousands of NHS patients with obesity could soon access support through digital platforms and pharmacies under a new £85m programme. The scheme will offer weight management support via digital tools, community-based access points and pharmacies, with eligible patients in participating areas potentially starting from summer 2026. It aims to ease pressure on the [...]

  • Roundup: discover the latest in AI-preventative care and more

    Age Tech World explores the latest business developments in the world of ageing and longevity. Klotho Neurosciences to expand development programmes beyond neurology Klotho Neurosciences has announced that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain function, organ health, and longevity. In addition to its core programmes targeting brain [...]

  • Klotho targets ageing beyond brain health

    Klotho Neurosciences is exploring new technologies to support brain function, muscle strength, bone health and other key indicators of ageing. The NASDAQ-listed biogenetics company said it plans to move beyond its core focus on brain ageing and neurodegenerative diseases such as ALS, Alzheimer’s and Parkinson’s. It is now evaluating technologies that complement its anti-ageing Klotho [...]

  • Shoulder Innovations plans US$100m IPO

    Shoulder Innovations is planning to raise around US$100m in an IPO as it looks to expand its orthopaedic implant business in the US and globally. The company will offer 5 million shares on the New York Stock Exchange, priced between US$19 and US$21 each, and will trade under the ticker SI. Founded in 2009, Shoulder [...]

  • Avalyn raises US$100m for lung disease treatments

    Avalyn Pharma has raised US$100m in new funding to develop inhaled therapies for rare lung diseases including pulmonary fibrosis. The clinical-stage biopharmaceutical company, formerly known as Genoa Pharmaceuticals, has now raised around US$300m since its launch in 2011. Its lead programmes target inhaled versions of existing drugs for pulmonary fibrosis—a condition that causes lung scarring [...]

  • Research roundup: Weekly injection could be life changing for Parkinson’s patients, and more

    Agetech World explores the latest developments in the world of age technology and longevity - from the effects of long-term obesity and biological ageing in young adults to understanding how math can help unlock the body’s hidden blueprint for staying healthy. Weekly injection could be life changing for Parkinson’s patients Scientists have developed a long-acting [...]

  • Round up: US$12m to accelerate research in longevity, new partnership to accelerate Alzheimer’s drug discovery, and more

    Age Tech World explores the latest developments in business in the world of ageing and longevity. US$12m to accelerate research in longevity Longevity startup Circulate Health has announced that it raised US$12m in seed funding. The company’s patented method of therapeutic plasma exchange uses a procedure that separates, removes, and replaces a patient's plasma to [...]

  • Injectable weight-loss drugs deliver lower results in real-world use, study shows

    Semaglutide and tirzepatide, injectable medications prescribed for obesity, are producing smaller weight loss in everyday clinical use than in trials, mainly due to early treatment discontinuation and lower maintenance doses, a large study has found. Researchers tracking 7,881 adults with severe obesity found a notable gap between the weight loss achieved in randomised trials and [...]

  • How older adults adapted to Covid-19

    Public healthcare emergencies, such as the Covid-19 pandemic, can drastically disrupt healthcare systems with long-term repercussions. The effects of such healthcare crises are more pronounced in the ageing population, who are particularly vulnerable to chronic infections and sudden disruptions in healthcare. The Covid-19 outbreak that emerged in December 2019 quickly spread worldwide, and several emergency [...]

  • Current tests are not catching cancer recurrence early enough, say oncologists

    In a new report, oncologists reveal they are seeing more and more patients with advanced cancers, and worry that current tests may not catch cancer recurrence early enough. Based on a survey conducted by The Harris Poll on behalf of Quest Diagnostics, the new report highlights perspectives of medical and surgical oncologists about the prevalence [...]